This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Trysberg, E Articles by Tarkowski, A Search for Related Content PubMed PubMed Citation Articles by Trysberg, E Articles by Tarkowski, A Social Bookmarking                         What's this?

Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement

Department of Rheumatology, University of Göteborg, Sweden;Department of Rheumatology, University of Göteborg, Guldhedsgatan 10, S-413 46 Göteborg, Sweden. Tel: (/ 46) 31 342 64 52; Fax: (/ 46) 31 82 39 25; estelle{at}immuno.gu.se

H Carlsten

A Tarkowski

Department of Rheumatology, University of Göteborg, Sweden

Symptoms originating from central nervous system (CNS) are frequently occuring in patients with systemic lupus erythematosus (SLE). Reliable diagnostic markers for this condition are presently lacking. Importantly, CNS involvement in lupus patients is associated with increased morbidity and mortality. The aim of this retrospective evaluate was to study the diagnostic value of cerebrospinal fluid (CSF) cytokine levels in SLE patients with CNS involvement.

34 patients with SLE were hospitalized and investigated for the presence of CNS lupus. These patients were evaluated clinically and with magnetic resonance imaging (MRI) and CSF analyses, as well as with neuropsychiatric tests. 13 patients were found to have CNS lupus whereas another four of the patients fulfilled the criteria for CNS involvement but were excluded from this group due to other causes of CNS involvement. Lastly, in 17 SLE cases, the diagnosis of CNS lupus could not be confirmed.

CSF levels of interleukin-6 (IL-6) and IL-8, as well as the CSF/serum IL-6 ratio, were elevated in the CNS lupus group, compared with the 17 SLE patients not fullfilling a diagnosis of cerebral lupus. Interestingly, follow-up of five patients being successfully treated for CNS lupus revealed profound decrease of intrathecal IL-6 levels. These results indicate that analysis of CSF cytokine levels, especially IL-6 and IL-8, may be useful in the diagnostics and possibly follow-up of SLE patients with cerebral lupus.

Key Words: cytokines • SLE • CNS • autoimmunity • brain

Lupus, Vol. 9, No. 7, 498-503 (2000)
DOI: 10.1177/096120330000900704


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D. M. Santer, T. Yoshio, S. Minota, T. Moller, and K. B. Elkon Potent Induction of IFN-{alpha} and Chemokines by Autoantibodies in the Cerebrospinal Fluid of Patients with Neuropsychiatric Lupus J. Immunol., January 15, 2009; 182(2): 1192 - 1201. [Abstract] [Full Text] [PDF]

				P. Bartolucci, S. Brechignac, P. Cohen, V. Le Guern, and L. Guillevin Adjunctive plasma exchanges to treat neuropsychiatric lupus: a retrospective study on 10 patients Lupus, October 1, 2007; 16(10): 817 - 822. [Abstract] [PDF]

				F. G. Joseph, G. A. Lammie, and N. J. Scolding CNS lupus: A study of 41 patients Neurology, August 14, 2007; 69(7): 644 - 654. [Abstract] [Full Text] [PDF]

				D. Ding, H. Mehta, W. J. McCune, and M. J. Kaplan Aberrant Phenotype and Function of Myeloid Dendritic Cells in Systemic Lupus Erythematosus J. Immunol., November 1, 2006; 177(9): 5878 - 5889. [Abstract] [Full Text] [PDF]

				E Sato, N Iikuni, T Yoshio, S Minota, N Kamatani, and H Okamoto Soluble fractalkine in the cerebrospinal fluid of patients with neuropsychiatric lupus Ann Rheum Dis, September 1, 2006; 65(9): 1257 - 1259. [Full Text] [PDF]

				N Iikuni, H Okamoto, T Yoshio, E Sato, S Kamitsuji, T Iwamoto, S Momohara, A Taniguchi, H Yamanaka, S Minota, et al. Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus Ann Rheum Dis, February 1, 2006; 65(2): 253 - 256. [Abstract] [Full Text] [PDF]

				H. Okamoto, N. Iikuni, S. Kamitsuji, T. Yoshio, S. Minota, and N. Kamatani IP-10/MCP-1 ratio in CSF is an useful diagnostic marker of neuropsychiatric lupus patients Rheumatology, February 1, 2006; 45(2): 232 - 234. [Full Text] [PDF]

				A Jonsen, A A Bengtsson, O Nived, B Ryberg, L Truedsson, L Ronnblom, G V Alm, and G Sturfelt The heterogeneity of neuropsychiatric systemic lupus erythematosus is reflected in lack of association with cerebrospinal fluid cytokine profiles Lupus, November 1, 2003; 12(11): 846 - 850. [Abstract] [PDF]